<style face="normal" font="default" size="100%">Crystal structure of a 1:1 co-crystal of the anti-cancer drug gefitinib with azelaic acid </style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Crystal structure of a 1:1 co-crystal of the anti-cancer drug gefitinib with azelaic acid </style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Drug-drug cocrystals of anticancer drugs erlotinib-furosemide and gefitinib-mefenamic acid for alternative multi-drug treatment</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Polymorphs and hydrates of the anticancer drug erlotinib: X-ray crystallography, phase transition and biopharmaceutical studies</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Novel crystal forms of Entresto: a supramolecular complex of trisodium sacubitril/valsartan hemi-pentahydrate</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Tridentate NacNac stabilized tin and nickel complexes: access to a monomeric nickel hydride and its catalytic application</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Polymorph II of hydroxyurea 150 years after its first synthesis</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Rivaroxaban eutectics with improved solubility, dissolution rates, bioavailability and stability</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Tridentate NacNac tames T-shaped nickel(I) radical</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Cocrystals of the highly potent sickle cell anemia drug voxelotor with trimesic acid: a substantial enhancement in in vitro dissolution performance at physiological pH</style>